Evinova will operate as a separate health-tech business within AstraZeneca to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

“Evinova’s globally-scaled digital health solutions are evidence-led, science-based and human experience-driven to serve clinical trial sponsors, clinical research organisations (CROs), clinical trial site care teams and patients,” states the company in a press release. First strategic collaborations with CROs Parexel and Fortrea enable Evinova’s digital health solutions to be offered to their wide customer base.

“The future of medicine development can be accelerated with digital solutions. We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions,” says Pascal Soriot, Chief Executive Officer, AstraZeneca.

Evinova

Evinova will prioritize bringing to market established and scaled digital technology solutions already being used globally by AstraZeneca to optimize clinical trial design and delivery, the company states. Evinova will also pursue opportunities in digital remote patient monitoring and digital therapeutics with a pipeline of digital innovations in these areas.

“We are excited to bring the portfolio of globally-scaled digital solutions developed to serve AstraZeneca’s drug development pipeline to the wider life sciences community. We believe this will help propel the sector forward in digital health, as we know healthcare professionals and regulators need digital solutions that work across pharma and support patients broadly. Coming from within the sector and with proven experience, Evinova will be uniquely placed to deliver science-based, evidence-led and human experience-driven solutions with the aim of improving patient experience and outcomes,” says Cristina Duran, President of Evinova.

Collaborations with CROs, Accenture and Amazon Web Services

Globally-leading CROs Parexel and Fortrea have entered into agreements to offer Evinova digital health solutions to their wide customer base. To accelerate industry adoption and sustain and expand the global reach of its digital products, Evinova is collaborating with Accenture and Amazon Web Services.

Evinova will combine clinical and regulatory experience gained at AstraZeneca with its deep expertise in digital technology spanning strategy and development, digital product development, data science and AI, user experience design and behavioural science. In addition to digital solutions, Evinova will offer custom scientific solutions, including remote patient monitoring and novel endpoint solutions, as well as trial design and consulting services, it states.

Photo of Pascal Soriot: AstraZeneca